alexa Development And In-vivo Evaluation Of Ofloxacin Gastro-retentive Drug Delivery System
ISSN: 1948-593X

Journal of Bioanalysis & Biomedicine
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Share This Page

Additional Info

Loading Please wait..

7th European Biosimilars Congress
May 15-16, 2017 Munich, Germany

Dina E Abo Elezz, Ahmed H El-Shafeey and Yousry M El-Sayed
Pharos University, Egypt
CairoUniversity, Egypt
ScientificTracks Abstracts: J Bioanal Biomed
DOI: 10.4172/1948-593X-C1-026
Ofloxacin is readily soluble in the acidic environment of the stomach, following oral administration; there is rapid and extensive oral absorption from the gastrointestinal tract. Gastric retention is designed to prolong gastric residence time of oral controlled release dosage forms which enhance therapeutic efficacy, reduce time intervals for drug administration, potentially reduced dose size and thus improved patient compliance. Factorial designs of 23 were planned for the optimization of ofloxacin floating and size increasing tablets, using Design-Expert® software. Convenient parameters which measures the floating lag time, floating duration, size increasing behavior, t50% and drug release tests were performed in 0.1 N HCl at 37ºC of the suggested formulations of the design, where different concentrations of different polymers (HPMC K100M, HPMC K15M and PEO wsr303) were used. Responses of the floating preparation were principally related to the polymer type rather than polymer concentration, while responses of the size increasing preparation were related to both polymer type and concentration. Comparative randomized, single dose, three-way crossover open label study was done to evaluate in vivo release and pharmacokinetics parameters of two different ofloxacin gastroretentive tablets 400 mg/tablet (test product 1, 2) relative to Tarivid® conventional tablet (2x200 mg/tablet) (reference product) after single oral administration to six healthy adult males as shown in Figure 1. Drugs were administered to fasted volunteers and blood samples were collected up to 24 hours and assayed for ofloxacin using a validated LC-MS/MS method. The pharmacokinetic parameters AUC0-t, AUC0-∞, Cmax, Tmax, T1/2, MRT and elimination rate constant were determined from plasma concentration-time profile by non-compartmental analysis method.

Dina E Abo Elezz works as an Assistant Lecturer in the Faculty of Pharmacy, Pharos University in Alexandria, Egypt. She has done her Master’s degree in Pharmaceutical Sciences from Cairo University, Egypt. She is experienced in research and teaching. Her research interests are in pharmaceutical sciences, pharmacokinetics, bioavailability, bioequivalence and biosimilar.

Email: [email protected]

image PDF   |   image HTML
Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version